Position in OGN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,110
+$619 QoQ
Shares Held
82
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#461
of 626 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON INVESTMENT MANAGEMENT, INC. holds $48,347,417 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
48,713 | $12,371,640 | |
| 2 | PFE |
Pfizer Inc
|
469,287 | $11,300,430 | |
| 3 | ABBV |
AbbVie Inc.
|
34,736 | $8,740,967 | |
| 4 | AMGN |
Amgen Inc
|
18,002 | $6,518,884 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,721 | $6,091,644 | |
| 6 | MRK |
Merck & Co., Inc.
|
24,470 | $3,144,395 | |
| 7 | GSK |
GSK plc
|
1,680 | $88,065 | |
| 8 | AZN |
Astrazeneca PLC
|
324 | $61,436 |
All Filings in OGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,110 | 82 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $491 | 82 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $587 | 82 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $875 | 82 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $793 | 82 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,220 | 82 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,223 | 82 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,568 | 82 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,697 | 82 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $1,541 | 82 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,182 | 82 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,423 | 82 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,706 | 82 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,928 | 82 | Shares | Sole | 2023-04-24 | |
| No filing history on record for this holder in this stock. | ||||||